Characterization of a Prototype Compact High Gradient Magnetic Separator Device for Blood Detoxification

Abstract A prototype compact magnetic separator device for human blood detoxification was characterized using blood-mimicking fluid (ethylene glycol-water solution) as well as whole blood. Magnetic separation at various applied magnetic fields (0.125, 0.33, and 0.44 T) and various flow rates (3.1–29.5 ml/min) showed that the device could efficiently separate magnetic spheres from blood-mimicking fluid at a moderate applied magnetic field (for example, <0.44 T) and relatively high flow rates (for example, ≤29.5 ml/min). The experiments done in flow circulation systems showed that higher flow rates might shorten the sphere recovery time and accelerate the detoxification process. In vitro separation from flowing blood showed that it is possible to use the device to efficiently recover spheres in a reasonably short time (≤60 min). Moreover, it was also demonstrated that the separator had little effect on the occurrence of hemolysis. All the results revealed that the separator could be a clinically applicable device for efficient separation of magnetic spheres from blood flow for human detoxification purpose.

[1]  J. A. Ritter,et al.  Theoretical Analysis of a Magnetic Separator Device for Ex‐Vivo Blood Detoxification , 2008 .

[2]  J. A. Ritter,et al.  A comprehensive in vitro investigation of a portable magnetic separator device for human blood detoxification , 2007, Physics in medicine and biology.

[3]  Dietmar Rempfer,et al.  Three-dimensional modeling of a portable medical device for magnetic separation of particles from biological fluids , 2007, Physics in medicine and biology.

[4]  Armin D. Ebner,et al.  In vitro study of ferromagnetic stents for implant assisted-magnetic drug targeting , 2007 .

[5]  A. Rosengart,et al.  Magnetic separation of micro-spheres from viscous biological fluids , 2007, Physics in medicine and biology.

[6]  Armin D. Ebner,et al.  Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent—2: Parametric study with multi-wire two-dimensional model , 2005 .

[7]  Armin D. Ebner,et al.  Theoretical analysis of a transdermal ferromagnetic implant for retention of magnetic drug carrier particles , 2005 .

[8]  S. Justesen,et al.  Superparamagnetic Cation–Exchange Adsorbents for Bioproduct Recovery from Crude Process Liquors by High-Gradient Magnetic Fishing , 2004 .

[9]  Armin D. Ebner,et al.  Application of high gradient magnetic separation principles to magnetic drug targeting , 2004 .

[10]  U. Häfeli,et al.  Magnetically modulated therapeutic systems. , 2004, International journal of pharmaceutics.

[11]  J. Rosenecker,et al.  The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery , 2003, Biological chemistry.

[12]  Matthias Franzreb,et al.  A novel high-gradient magnetic separator (HGMS) design for biotech applications , 2002 .

[13]  W. Clark,et al.  Properties of Membranes Used for Hemodialysis Therapy , 2002, Seminars in dialysis.

[14]  M. Portaccio,et al.  The α1-antitrypsin/elastase Complex as an Experimental Model for Hemodialysis in Acute Catabolic Renal Failure, Extracorporeal Blood Circulation and Cardiocirculatory Bypass , 2002 .

[15]  S. A. Gómez-Lopera,et al.  Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[16]  C Alexiou,et al.  Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.

[17]  M C Yang,et al.  In vitro characterization of the occurrence of hemolysis during extracorporeal blood circulation using a mini hemodialyzer. , 2000, ASAIO journal.

[18]  Peter Babinec,et al.  Site-Specific in vivo Targeting of Magnetoliposomes Using Externally Applied Magnetic Field , 2000, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[19]  Carl K. Hoh,et al.  Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy , 1999 .

[20]  G. Zilleruelo,et al.  Quantitation of Comparative Thrombogenicity of Dog, Pig, and Human Platelets in a Hemodialyzer , 1992, ASAIO journal.

[21]  K. Widder,et al.  Magnetic guidance of drug‐carrying microspheres , 1978 .

[22]  Michael D Kaminski,et al.  A novel human detoxification system based on nanoscale bioengineering and magnetic separation techniques. , 2007, Medical hypotheses.

[23]  M. Portaccio,et al.  The alpha1-antitrypsin/elastase complex as an experimental model for hemodialysis in acute catabolic renal failure, extracorporeal blood circulation and cardiocirculatory bypass. , 2002, International Journal of Artificial Organs.

[24]  J Henke,et al.  Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo , 2002, Gene Therapy.

[25]  V. Torchilin,et al.  Drug targeting. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  R D Swartz,et al.  Preservation of plasma volume during hemodialysis depends on dialysate osmolality. , 1982, American journal of nephrology.